SCHEMBL4269788

SCHEMBL4269788

CCc1nccn1-c1cc(N)cc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR2E1 Q9Y466 1/20 0.47
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
F2 P00734 2/20 0.35
F10 P00742 2/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
BRD9 Q9H8M2 1/20 0.34
ALOX15B O15296 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
KCNH2 Q12809 2/20 0.31
ABL1 P00519 1/20 0.31
KDR P35968 2/20 0.31
FLT1 P17948 1/20 0.31
FLT4 P35916 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL589410 0.85 NR2E1 (0.44) NR2E1F2F10KDM4EALDH1A1
SCHEMBL710630 0.81 NR2E1 (0.54) NR2E1F2F10KDM4EALDH1A1
SCHEMBL22729958 0.80 NR2E1 (0.39) NR2E1F2F10ABL1
SCHEMBL8429953 0.76 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL28005753 0.74 NPC1 (0.48) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10902250 0.74 MAPT (0.43) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL13530934 0.70 NR2E1 (0.57) NR2E1ALDH1A1NOS3NOS2MAPT
SCHEMBL8830212 0.69 CYP3A4 (0.54) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL8739094 0.67 NR2E1 (0.50) NR2E1NOS3NOS2MAPTTSHR
SCHEMBL12012876 0.67 NR2E1 (0.62) NR2E1ALDH1A1NOS3NOS2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176781-A1 Acetylenic Heteroaryl Compounds ARIAD PHARMACEUTICALS, INC. 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176781-A1 Acetylenic Heteroaryl Compounds NAT1, AADAC, ACACA NR2E1 1890/4885PDE4A 3425/4885PDE4B 3236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.